153254-09-2OB(O)c1ccc(C(F)(F)F)cc1C(F)(F)FWLYPBMBWKYALCG-UHFFFAOYSA-N153254-09-2DTXSID20382198Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 8 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
VerwendenReactant for preparation of:Pyrrolo[2,3-d]pyrimidin-4-ones as corticotropin-releasing factor 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptorBiaryl pyrazole carboxamides as sodium channel blockers for treatment of neuropathic painBiphenylketones as dual modulators of inflammation and bone loss(Biphenylyl)pyrazolecarboxamides and their voltage-gated sodium channel Nav1.7 blocking structure-activity relationshipN-hydroxyalkyl biphenylsulfonamides as inhibitors of bone resorption1,3,6,8a-tetraazaacenaphthylene derivatives and study of their activity as corticotropin-releasing factor-1 antagonistsBlue luminescent iridium phenylpyridine complexes
Wird geladen…
Wird geladen…
Wird geladen…